Motaz Qadan, MD, PhD, is a hepatobiliary and pancreatic surgical oncologist at the MGH. He is a high volume pancreas and liver specialized surgeon with excellent outcomes. He is surgical director of the Mass General Cancer Center and Section Head of the Hepatobiliary/Liver Program at the MGH. Patient information videos about his common operations are included below:
Dr. Qadan's leadership positions include:
Dr. Qadan received his undergraduate and medical degrees from the University of Edinburgh Medical School, which is among the top medical schools in Western Europe. He completed surgical residency at Stanford University, where he served as administrative chief resident. Following this, he completed a fellowship in complex general surgical oncology at the Memorial Sloan Kettering Cancer Center in New York where he served as the educational coordinator.
Dr. Qadan is also a Fellow of the American College of Surgeons (FACS) and a Member of the Royal College of Surgeons of Edinburgh (MRCSEd). He is a surgical member of the multidisciplinary cancer team at the MGH.
Below are some additional sites of interest:
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Massachusetts General Hospital
55 Fruit St.
Boston, MA 02114
Phone: 617-643-5153
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
The Qadan laboratory focuses on the tumor microenvironment in pancreas cancer. Current scientific and translational efforts in his laboratory include the evaluation of the radiosensitizing effects of Losartan in orthotopic pancreatic cancer tumor models and new imaging biomarkers, such as Zinc magnetic resonance imaging, for early and accurate detection of pancreatic ductal adenocarcinoma.
Dr. Qadan is also interested in clinical outcomes health services research and leads a large group of researchers who focus on methods to collect, analyze, and improve outcomes related to cancer surgery at the institutional and national level. His projects have earned national recognition in the form of multiple prizes and awards over the last few months.
Dr. Qadan is an active clinical investigator in several high impact clinical trials. He is a principal investigator on a prehabilitation study entitled "Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program" where he enrolls patients in an exercise and nutrition program to improve their outcomes during treatment for pancreatic cancer.
Dr. Qadan is actively involved in many National societies and holds active leadership roles in several organizations. He has over 200 peer-reviewed scientific articles as well as several book chapters and scientific abstracts. Dr. Qadan is an active member of the Gastrointestinal Malignancies Program at the Dana-Farber/Harvard Cancer Center.
If you are interested in making a direct donation, please indicate the "Qadan Liver and Pancreas Research Fund". Donations are tax-deductible and handled by my colleague Ms. Meagan Coons of the MGH Development Office, 125 Nashua St, Suite 540, Boston, MA 02114. All donations are so greatly appreciated.
